• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6802220
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/06/2020
Event Type  malfunction  
Manufacturer Narrative
The customer reported a higher than expected vitros bhcg result on a single non-vitros biorad l1 compared to the vitros peer mean tested on a vitros 5600 integrated system.The assignable cause of the event is unknown.Improper sample handling cannot be ruled out as contributing to the event.It is possible the customer left the uncapped l1 control fluid on board the vitros instrument for >1 hour, although this cannot be confirmed.A vitros bhcg reagent related issue cannot be ruled out as there were insufficient data points to adequately assess vitros bhcg reagent lot 2680.In addition, a vitros instrument related issue did not likely contribute to the event as a vitros bhcg within-run precision test indicated vitros bhcg reagent lot 2680 was performing as expected on the vitros 5600 system.
 
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solutions center (tsc) to report higher than expected vitros total b-hcg ii (bhcg) results were obtained from a non-vitros seqc proficiency fluid tested on a vitros 5600 system.Biorad l1 bhcg result of 8.54 miu/ml vs the vitros peer mean result of 5.40 miu/ml.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The customer made no allegation that erroneous patient results had been predicted or reported from the laboratory.There is no allegation of patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc.Complaint number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key10471345
MDR Text Key244361370
Report Number3007111389-2020-00113
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Other
Type of Report Initial
Report Date 08/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/09/2021
Device Catalogue Number6802220
Device Lot Number2680
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 08/07/2020
Initial Date FDA Received08/31/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/27/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-